(Circulation. 1995;92:1399-1407.)
© 1995 American Heart Association, Inc.
Articles |
From the Houston VA Medical Center (S.G.K., M.H.K., A.I.S.) and Rice University (J.L.M., J.D.H.), Houston, Tex; and the University of Massachusetts Medical School (A.D.M., S.E.B.) and the Medical Center of Central Massachusetts (D.R.), Worcester, Mass.
Correspondence to Andrew I. Schafer, Chief, Medical Service, Houston Veterans Affairs Medical Center, 2002 Holcombe Blvd, Houston, TX 77030.
Background Shear stressinduced platelet aggregation may initiate arterial thrombosis at sites of pathological blood flow. Shear stressinduced platelet aggregation is mediated by von Willebrand factor (vWf) binding to platelet membrane glycoprotein (GP) Ib and GP IIb/IIIa. Tissue-type plasminogen activator (TPA) induces thrombolysis in coronary arteries through the local generation of plasmin. Plasmin also proteolyses GP Ib and plasma vWf.
Methods and Results Because these effects could mitigate shear
stressinduced platelet aggregation, we investigated the effect of
fibrinolytic agents on platelet aggregation in response to a
pathological shear stress of 120 dynes/cm2 generated by a
cone-and-platen rotational viscometer. Plasmin inhibited shear
stressinduced aggregation of washed platelets, and this was
associated with a decrease in GP Ib. TPA, at concentrations
2000
IU/mL, significantly inhibited shear stressinduced platelet
aggregation of platelet-rich plasma without a decrease in
platelet GP Ib. In plasma-platelet mixing experiments, we
determined that the TPA effect was localized to plasma. Purified vWf
multimer degradation by TPA (in the presence of exogenous
plasminogen) was associated with the loss of the capacity
of vWf to support shear stressinduced platelet aggregation.
Conclusions These results demonstrate that TPA inhibits platelet aggregation in response to pathological shear stress by altering the multimeric composition of vWf. This effect of TPA on shear stressinduced platelet aggregation may contribute, along with fibrinolysis, to the therapeutic effect of TPA in restoring blood flow during acute coronary artery thrombosis.
Key Words: stress, shear enzymes plasminogen activators platelets
This article has been cited by other articles:
![]() |
S. D. Berkowitz, C. B. Granger, K. S. Pieper, K. L. Lee, J. M. Gore, M. Simoons, P. W. Armstrong, E. J. Topol, and R. M. Califf Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial Infarction Circulation, June 3, 1997; 95(11): 2508 - 2516. [Abstract] [Full Text] |
||||
![]() |
H. S. Friedman, W. J. Koroshetz, The Massachusetts General Hospital Stroke Service, N. Qureshi, J. R. Marler, The NINDS-PA Stroke Study Group, and G. J. del Zoppo Tissue Plasminogen Activator for Acute Ischemic Stroke N. Engl. J. Med., May 23, 1996; 334(21): 1405 - 1406. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |